Jane Street’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-12,178
| Closed | -$62K | – | 4228 |
|
|
2019
Q4 | $62K | Buy |
+12,178
| New | +$62K | ﹤0.01% | 3135 |
|
|
2019
Q3 | – | Sell |
-23,945
| Closed | -$148K | – | 4283 |
|
|
2019
Q2 | $148K | Buy |
+23,945
| New | +$148K | ﹤0.01% | 3193 |
|
|
2019
Q1 | – | Sell |
-24,654
| Closed | -$104K | – | 4005 |
|
|
2018
Q4 | $104K | Buy |
+24,654
| New | +$104K | ﹤0.01% | 2945 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4120 |
|
|
2018
Q2 | – | Sell |
-48,685
| Closed | -$363K | – | 3977 |
|
|
2018
Q1 | $363K | Buy |
48,685
+36,391
| +296% | +$271K | ﹤0.01% | 2374 |
|
|
2017
Q4 | $73K | Sell |
12,294
-738
| -6% | -$4.38K | ﹤0.01% | 2914 |
|
|
2017
Q3 | $96K | Buy |
+13,032
| New | +$96K | ﹤0.01% | 2738 |
|
|
2017
Q2 | – | Sell |
-50,488
| Closed | -$476K | – | 3417 |
|
|
2017
Q1 | $476K | Buy |
+50,488
| New | +$476K | ﹤0.01% | 1886 |
|
|
2016
Q2 | – | Sell |
-21,640
| Closed | -$94K | – | 3135 |
|
|
2016
Q1 | $94K | Buy |
21,640
+3,720
| +21% | +$16.2K | ﹤0.01% | 2432 |
|
|
2015
Q4 | $110K | Buy |
+17,920
| New | +$110K | ﹤0.01% | 2460 |
|
|
2015
Q3 | – | Sell |
-21,052
| Closed | -$157K | – | 3077 |
|
|
2015
Q2 | $157K | Buy |
+21,052
| New | +$157K | ﹤0.01% | 2266 |
|
|
2014
Q4 | – | Sell |
-43,559
| Closed | -$226K | – | 2584 |
|
|
2014
Q3 | $226K | Buy |
43,559
+27,018
| +163% | +$140K | ﹤0.01% | 1788 |
|
|
2014
Q2 | $71K | Buy |
+16,541
| New | +$71K | ﹤0.01% | 2120 |
|
|
2013
Q3 | – | Sell |
-19,134
| Closed | -$85K | – | 2973 |
|
|
2013
Q2 | $85K | Buy |
+19,134
| New | +$85K | ﹤0.01% | 2162 |
|